Letter: From Safety to Precision—Optimising the Use of <scp>GLP</scp> ‐1 Receptor Agonists in Gastroenterology: Authors' Reply

Institutions

Publication Details

Journal
Alimentary Pharmacology & Therapeutics
Published
2026-03-24
DOI
https://doi.org/10.1111/apt.70547
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Letter: From Safety to Precision—Optimising the Use of GLP ‐1 Receptor Agonists in Gastroenterology: Authors' Reply

Alimentary Pharmacology & Therapeutics
Diabetes Treatment and Management
article

Letter: From Safety to Precision—Optimising the Use of GLP ‐1 Receptor Agonists in Gastroenterology: Authors' Reply

article en

Abstract

No abstract available for this paper.
Alimentary Pharmacology & TherapeuticsVol. 63(8)
Columbia University Irving Medical Center (US), Mayo Clinic in Florida (US)
Good health and well-being
Openalex Percentile: Top 13%
Diabetes Treatment and Management
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Letter: From Safety to Precision—Optimising the Use of <scp>GLP</scp> ‐1 Receptor Agonists in Gastroenterology: Authors' Reply · Alimentary Pharmacology & Therapeutics (2026) | TGRS Research Map | TGRS